Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 17.13% vs 1.33% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 2.25% vs -24.12% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -6.84% vs -10.36% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 39.13% vs -34.29% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Lincoln Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 7.94% vs -5.34% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 17.13% vs 1.33% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -43.61% vs 211.52% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 2.25% vs -24.12% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -13.63% vs 10.38% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -6.84% vs -10.36% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 23.08% vs -3.70% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 39.13% vs -34.29% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025